April 2, 2013 /PRNewswire/ -- In a one-year period, prescriptions for non-steroidal anti-inflammatory drugs (NSAIDs) cost the average consumer
$2420. There are 33 million regular users of NSAIDs, and each user on average pays an additional
$700 annually to treat side effects caused by their NSAIDs prescriptions. That's the takeaway from a study of current literature commissioned by Vireo Systems, Inc., the maker of
AminoActiv®, a compelling new alternative to traditional NSAIDs.
The study compared AminoActiv with both prescription and generic NSAIDs and presented the following findings:
Annual Cost of Treatment Per Person:
- AminoActiv: $600
- Prescription NSAIDs: $2420
Side Effects Cost:
- AminoActiv: $0
- Prescription NSAIDs: $700
"The costs for just the side effects component of NSAID treatment exceed the total cost of AminoActiv treatment," stated Vireo Systems president
. "To express it another way, if NSAID users obtained their prescriptions for free, they still would pay more to treat
NSAID side effects
AminoActiv offers comparable levels of pain and inflammation relief for a variety of chronic and acute conditions, along with promotion of more rapid healing, no known side effects, and no known toxicities or drug interactions.
Alternatives to NSAID treatment, including AminoActiv, are gaining traction for two major reasons. First, consumers are becoming more cognizant of the risks inherent in standard prescriptions like ibuprofen, naproxen (e.g. Naprosyn®), celecoxib (e.g. Celebrex®), and diclofenac. These risks include gastrointestinal issues, renal problems and cardiac complications. The risks are even greater for senior citizens. It is common for these side effects to result in hospitalization that costs between
$15,000 and $20,000
Second, there is a large group of consumers whose chronic diseases or organ sensitivities discourage or prevent them from using NSAIDs to alleviate pain.